COVID-19 in patients with hematologic malignancy
P Langerbeins, M Hallek - Blood, The Journal of the American …, 2022 - ashpublications.org
The coronavirus infectious disease (COVID-19) shows a remarkable symptomatic
heterogeneity. Several risk factors including advanced age, previous illnesses, and a …
heterogeneity. Several risk factors including advanced age, previous illnesses, and a …
The importance of measuring SARS-CoV-2-specific T-cell responses in an ongoing pandemic
Neutralizing antibodies are considered a correlate of protection against SARS-CoV-2
infection and severe COVID-19, although they are not the only contributing factor to …
infection and severe COVID-19, although they are not the only contributing factor to …
The WSES/SICG/ACOI/SICUT/AcEMC/SIFIPAC guidelines for diagnosis and treatment of acute left colonic diverticulitis in the elderly
Acute left colonic diverticulitis (ALCD) in the elderly presents with unique epidemiological
features when compared with younger patients. The clinical presentation is more nuanced in …
features when compared with younger patients. The clinical presentation is more nuanced in …
Immunogenicity and risks associated with impaired immune responses following SARS-CoV-2 vaccination and booster in hematologic malignancy patients: an …
N Uaprasert, P Pitakkitnukun… - Blood Cancer …, 2022 - nature.com
Patients with hematologic malignancies (HM) have demonstrated impaired immune
responses following SARS-CoV-2 vaccination. Factors associated with poor immunogenicity …
responses following SARS-CoV-2 vaccination. Factors associated with poor immunogenicity …
[HTML][HTML] Emergence of Delta and Omicron variants carrying resistance-associated mutations in immunocompromised patients undergoing sotrovimab treatment with …
C Andrés, A González-Sánchez, M Jiménez… - Clinical Microbiology …, 2023 - Elsevier
Objectives To monitor the early emergence of genetic mutations related to reduced
susceptibility to monoclonal anti-body (mAb)-based treatment in immunocompromised …
susceptibility to monoclonal anti-body (mAb)-based treatment in immunocompromised …
Robust SARS-CoV-2 T cell responses with common TCRαβ motifs toward COVID-19 vaccines in patients with hematological malignancy impacting B cells
Immunocompromised hematology patients are vulnerable to severe COVID-19 and respond
poorly to vaccination. Relative deficits in immunity are, however, unclear, especially after 3 …
poorly to vaccination. Relative deficits in immunity are, however, unclear, especially after 3 …
SARS-CoV-2 in immunocompromised individuals
S DeWolf, JC Laracy, MA Perales, M Kamboj… - Immunity, 2022 - cell.com
Immunocompromised individuals and particularly those with hematologic malignancies are
at increased risk for SARS-CoV-2-associated morbidity and mortality due to immunologic …
at increased risk for SARS-CoV-2-associated morbidity and mortality due to immunologic …
SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immune responses and
infection outcomes were evaluated in 2,686 patients with varying immune-suppressive …
infection outcomes were evaluated in 2,686 patients with varying immune-suppressive …
[HTML][HTML] Immunogenicity of SARS-CoV-2 vaccines in patients with cancer
H Kakkassery, E Carpenter, PEM Patten… - Trends in Molecular …, 2022 - cell.com
Transmission of the SARS-CoV-2 virus and its corresponding disease (COVID-19) has been
shown to impose a higher burden on cancer patients than on the general population …
shown to impose a higher burden on cancer patients than on the general population …
Adult patients with cancer have impaired humoral responses to complete and booster COVID-19 vaccination, especially those with hematologic cancer on active …
E Liatsou, I Ntanasis-Stathopoulos, S Lykos… - Cancers, 2023 - mdpi.com
Simple Summary Taking into consideration the high risk of patients with cancer for severe
COVID-19 infection, prioritization has been given to primary prevention with both primary …
COVID-19 infection, prioritization has been given to primary prevention with both primary …